Dr. Clara Curiel-Lewandrowski has been accepted into the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) program. The program aims to expand the pool of qualified women candidates for leadership positions in academic medicine.

Dr. Clara Curiel-Lewandrowski discusses innovative skin cancer prevention, detection, and treatment modalities.

BIO5 researchers are tackling one of the world’s leading health scourges with new prevention, diagnostic, and treatment approaches.

UArizona's research and development expenditures ranked in the top 4% of all U.S. universities and topped the astronomy and astrophysics category, according to fiscal year 2020 data from the National Science Foundation.

Some people who develop skThe University of Arizona Skin Cancer Institute's Dr. Clara Curiel is identifying specific biomarkers that can identify those who don't typically fall within high-risk groups.

Leaders at the University of Arizona Skin Cancer Institute are focused on finding new therapies and treatments to help patients prevent and treat melanoma.

The UArizona Cancer Center continues to train the next generation of cancer scientists with help from UArizona researchers like BIO5 members Drs. Clara Curiel, Gregory Rogers, Cindy Miranti, Juanita Merchant, and Curtis Thorne.

The latest in skin cancer treatment and prevention methods.

Some may see the introduction of AI into healthcare as a threat, but BIO5 member Dr. Curiel-Lewandrowski, sees it as a transformational opportunity

Dr. Clara Curiel of The BIO5 Institute and Dr. Sally Disckinson discuss methods of skin cancer prevention.

The BIO5 Institute's Dr. Clara Curiel-Lewandrowski honored by AZBio as the 2018 Bioscience Researcher of the Year

A quick melanoma screening is a small process that can have immeasurable benefits, suggests The BIO5 Institute's Dr. Clara Curiel